Literature DB >> 22143355

Role of thymidylate synthase and dihydropyrimidine dehydrogenase mRNA in intrahepatic cholangiocarcinoma.

Yuji Morine1, Mitsuo Shimada, Tohru Utsunomiya, Satoru Imura, Tetsuya Ikemoto, Jun Hanaka, Mami Kanamoto, Nobuhiro Kurita, Hidenori Miyake.   

Abstract

PURPOSE: Thymidylate synthase (TS) and dihydropyrimidine dehydrogenase (DPD) are important enzymes in the metabolism of 5-fluorouracil and possible predictive markers. We conducted this study to clarify if TS and DPD gene expressions are a prognostic indicator for intrahepatic cholangiocarcinoma (IHCC).
METHODS: The subjects of this study were 21 patients with IHCC who had undergone surgical resection. Intratumoral TS and DPD mRNA expressions were examined using the Danenberg tumor profile method and classified into two groups according to the median value of each. We then compared the clinicopathological variables, including prognosis, between the high and low expression groups.
RESULTS: Low DPD expression was correlated with macroscopic type, namely, mass-forming + infiltrative (P = 0.08). Postoperative survival rates in the low DPD expression group were significantly lower than those in the high DPD expression group. Multivariate analysis revealed macroscopic type to be an independent prognostic factor, whereas TS mRNA expression did not correlate with any clinicopathological variables, including prognosis.
CONCLUSIONS: Low DPD mRNA expression was related to macroscopic type and associated with poor prognosis. DPD mRNA expression in tumor cells is suggested to be an important regulator of malignant behavior in IHCC.

Entities:  

Mesh:

Substances:

Year:  2011        PMID: 22143355     DOI: 10.1007/s00595-011-0054-z

Source DB:  PubMed          Journal:  Surg Today        ISSN: 0941-1291            Impact factor:   2.549


  33 in total

1.  Extended resection for intrahepatic cholangiocarcinoma in Japan.

Authors:  M Yamamoto; K Takasaki; T Yoshikawa
Journal:  J Hepatobiliary Pancreat Surg       Date:  1999

2.  Surgical treatment of cholangiocarcinoma.

Authors:  F F Chou; S M Sheen-Chen; Y S Chen; M C Chen; C L Chen
Journal:  Hepatogastroenterology       Date:  1997 May-Jun

3.  Real time quantitative PCR.

Authors:  C A Heid; J Stevens; K J Livak; P M Williams
Journal:  Genome Res       Date:  1996-10       Impact factor: 9.043

4.  Intrahepatic cholangiocarcinoma.

Authors:  K M Chu; E C Lai; S Al-Hadeedi; C E Arcilla; C M Lo; C L Liu; S T Fan; J Wong
Journal:  World J Surg       Date:  1997 Mar-Apr       Impact factor: 3.352

5.  Pyrimidine base degradation in cultured murine C-1300 neuroblastoma cells and in situ tumors.

Authors:  M Tuchman; R F O'Dea; M L Ramnaraine; B L Mirkin
Journal:  J Clin Invest       Date:  1988-02       Impact factor: 14.808

6.  Thymidylate synthetase: mechanism of inhibition by 5-fluoro-2'-deoxyuridylate.

Authors:  R J Langenbach; P V Danenberg; C Heidelberger
Journal:  Biochem Biophys Res Commun       Date:  1972-09-26       Impact factor: 3.575

7.  Significance of dihydropyrimidine dehydrogenase and thymidylate synthase mRNA expressions in hepatocellular carcinoma.

Authors:  Akira Nii; Mitsuo Shimada; Toru Ikegami; Yukari Harino; Satoru Imura; Yuji Morine; Hirofumi Kanemura; Yusuke Arakawa; Koji Sugimoto
Journal:  Hepatol Res       Date:  2008-11-25       Impact factor: 4.288

Review 8.  Intrahepatic cholangiocarcinoma arising 34 years after excision of a type IV-A congenital choledochal cyst: report of a case.

Authors:  Kazuhiko Shimamura; Isao Kurosaki; Daisuke Sato; Kabuto Takano; Naoyuki Yokoyama; Yoshinobu Sato; Katsuyoshi Hatakeyama; Keiko Nakadaira; Minoru Yagi
Journal:  Surg Today       Date:  2009-03-12       Impact factor: 2.549

9.  Aggressive surgical treatment of intrahepatic cholangiocarcinoma: predictors of outcomes.

Authors:  S Roayaie; J V Guarrera; M Q Ye; S N Thung; S Emre; T M Fishbein; S R Guy; P A Sheiner; C M Miller; M E Schwartz
Journal:  J Am Coll Surg       Date:  1998-10       Impact factor: 6.113

10.  Intrahepatic peripheral cholangiocarcinoma: mode of spread and choice of surgical treatment.

Authors:  A Sasaki; M Aramaki; K Kawano; Y Morii; K Nakashima; T Yoshida; S Kitano
Journal:  Br J Surg       Date:  1998-09       Impact factor: 6.939

View more
  1 in total

1.  Concept mapping One-Carbon Metabolism to model future ontologies for nutrient-gene-phenotype interactions.

Authors:  A C Joslin; R Green; J B German; M C Lange
Journal:  Genes Nutr       Date:  2014-08-05       Impact factor: 5.523

  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.